Trusted Resources: Education
Scientific literature and patient education texts
Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the Literature
source: Journal of clinical medicine
year: 2021
authors: Thomas S,Ramaswami U,Cleary M,Yaqub M,Raebel EM
summary/abstract:Mucopolysaccharidosis type III (MPS III, Sanfilippo disease) is a life-limiting recessive lysosomal storage disorder caused by a deficiency in the enzymes involved in degrading glycosaminoglycan heparan sulfate. MPS III is characterized by progressive deterioration of the central nervous system. Respiratory tract infections have been reported as frequent and as the most common cause of death, but gastrointestinal (GI) manifestations have not been acknowledged as a cause of concern. The aim of this study was to determine the incidence of GI problems as a primary cause of death and to review GI symptoms reported in published studies.
organization: The Society for Mucopolysaccharide and Related Diseases, MPS House, Amersham HP7 9LP, UK.DOI: 10.3390/jcm10194445
read more
Related Content
-
MPS IIIA (Sanfilippo Syndrome, Type A) in a 7-Year-Old Girlhttps://slideplayer.com/slide/13595382/...
-
Mucopolysaccharidosis Type III – Sanfilippo SyndromeMucopolysaccharidosis type III (MPS III)...
-
Cure Sanfilippo Foundation – TwitterCure Sanfilippo Foundation is 501c3 nonp...
-
Schizophreniform Presentation and Abrupt Neurologic Decline in a Patient With Late-Onset Mucopolysaccharidosis Type ...Due to their low frequency and some atyp...
-
Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) From Abeona ...Ultragenyx Pharmaceutical Inc. and Abeon...
-
Feeding Tips for Children With Sanfilippo SyndromeDisabilities due to Sanfilippo syndrome ...
-
Sleep-Related Hypermotor Epilepsy in a Patient With Mucopolysaccharidosis Type IIIBoth non-epileptic sleep disturbances an...